US Patent Family Members and Approved Drugs for Canada Patent: 2364960
✉ Email this page to a colleague
US Patent Family Members and Approved Drugs for Canada Patent: CA2364960
| US Patent Number | Estimated Patent Expiration | Generic Name | US Applicant | US Tradename |
|---|---|---|---|---|
| 6,207,858 | 2039-03-29 | ibritumomab tiuxetan | Acrotech Biopharma Llc | ZEVALIN |
| >US Patent Number | >Estimated Patent Expiration | >Generic Name | >US Applicant | >US Tradename |
